Home › BAXTER HEALTHCARE CORPORATION › FLOSEAL HEMOSTATIC MATRIX
FLOSEAL HEMOSTATIC MATRIX
BAXTER HEALTHCARE CORPORATION · Model ADS201883 · UDI-DI 00085412656304
PMX
Prescription
0
510(k) clearances
25
Adverse events
2
Recalls
12
Facilities
Description
Floseal Matrix is indicated in surgical procedures (other than in ophthalmic) as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical.
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2023-12-06 | Baxter Healthcare Corporation | Cardiovascular Surgery marketing brochure (US-AS46-220001) that was distributed for the products listed below contains inaccurate content that does not align with some of the produ |
| 2018-05-30 | Baxter Healthcare Corporation | Baxter r recalled this device due to the use of an incorrect plastic formulation in the manufacture of the blue luer component of the FLOSEAL malleable tips. |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.